Plain-English translation of NCT05559164 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether Lipitor, a cholesterol medication, can protect your heart while you receive targeted therapy for HER2-positive breast cancer. Some breast cancer treatments can stress the heart over time, and researchers want to see if adding this medication daily can prevent heart problems and help you complete your full cancer treatment without delays or interruptions.
Certain breast cancer drugs work very well but can sometimes weaken the heart muscle, which may force doctors to pause or stop treatment. This trial is exploring whether this medication can reduce that risk so more patients can stay on their cancer therapy without heart-related complications.
You likely qualify if…
You likely don't qualify if…
You will take Lipitor 40 mg by mouth once daily throughout your cancer treatment. You'll have regular appointments to monitor your heart health with heart imaging (like an echocardiogram), blood tests, and check-ins with your medical team. The study will track whether the medication helps prevent heart problems and allows you to complete your cancer therapy as planned.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States